Volume 14, Issue 57 (Dec 2006)                   J Adv Med Biomed Res 2006, 14(57): 39-44 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Khosravi H, Amini M, Haghighi S, Ghodsi D, Kosravi A, Kalateh Jari M. Case Report: Occurrence of Malignant Neuroleptic Syndrome Due to the Intake of Risperidone in Low-Risk Patients. J Adv Med Biomed Res 2006; 14 (57) :39-44
URL: http://journal.zums.ac.ir/article-1-131-en.html
Abstract:   (176666 Views)

Neuroleptic Malignant Syndrome (NMS) is a rare but potentially fatal problem induced by the consumption of antipsychotic drugs, especially traditional drugs which are more common in youngsters and males. This paper describes the first reported case of a clinical presentation of NMS (induced by the consumption of Risperidone) in an old woman, who was suffering from psychotic processes. Due to psychotic depression and with differential diagnosis of schizoaffective, the woman had been prescribed a low and medium dosage of Risperidone, but she suddenly and unexpectedly developed clinical NMS. Despite special treatments and services, she passed away after 14 days. In spite of rare universal reports regarding the development of NMS induced by the consumption of Risperidone, so far no occurrence of NMS in aged women has been reported.

Full-Text [PDF 149 kb]   (158257 Downloads)    
Type of Study: Original Research Article |
Received: 2007/11/13 | Accepted: 2014/06/30 | Published: 2014/06/30

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Journal of Advances in Medical and Biomedical Research

Designed & Developed by : Yektaweb